Synthesis, characterization and anticancer studies of ferrocenyl complexes containing thiazole moiety

Applied Organometallic Chemistry

Volumn 26, Issue 5, 2012, Pages 230-236

  Abd Elzaher, Mokhles M ^a   Moustafa, Samia A ^a   Labib, Ammar A ^a   Mousa, Hanan A ^a   Ali, Mamdouh M ^a   Mahmoud, Abeer E ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

anticancer; bioinorganic chemistry; ferrocene; Schiff bases; transition metal complexes

Indexed keywords

ANTICANCER; ANTICANCER ACTIVITIES; BIOINORGANIC CHEMISTRY; BREAST CANCER CELLS; CANCER CELLS; CIS-PLATIN; ELECTRONIC ABSORPTION; FERROCENES; FERROCENYL; FERROCENYL LIGANDS; GLUTATHIONE PEROXIDASE; MOLAR CONDUCTIVITIES; REACTIVE OXYGEN; REDUCED GLUTATHIONE; SCHIFF BASIS; SUPER OXIDE DISMUTASE;

BIOCHEMISTRY; CELL CULTURE; CELL DEATH; COBALT; COPPER COMPOUNDS; FREE RADICALS; IRON COMPOUNDS; LIGANDS; MAGNETIC SUSCEPTIBILITY; METAL COMPLEXES; NICKEL COMPOUNDS; ORGANOMETALLICS; OXYGEN; PEPTIDES; PLATINUM COMPOUNDS; TRANSITION METALS; ZINC COMPOUNDS;

SYNTHESIS (CHEMICAL);

EID: 84860247823     PISSN: 02682605     EISSN: 10990739     Source Type: Journal    
DOI: 10.1002/aoc.2844     Document Type: Article

References (56)

1. a) K. Singh, M. S. Barwa, P. Tyagi, Eur. J. Med. Chem. 2006, 41, 147
2. b) M. Gielen, E. R. T. Tiekink, Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, Wiley, New York, 2005.
3. M. Champdore, G. Fabio, A. Messere, D. Montesarchio, G. Pic- Cialli, R. Loddo, M. Collad, Tetrahedron 2004, 60, 6555.
4. E. Hillard, A. Vessières, L. Thouin, G. Jaouen, C. Amatore, Angew. Chem. Int. Edit. 2006, 45, 285.
5. G. M. Maguene, J. Jakhial, M. Ladyman, A. Vallin, D. A. Ralambomanana, T. Bousquet, J. Maugein, J. Lebibi, L. Pelinski, Eur. J. Med. Chem. 2011, 46, 31.
6. P. Stepnicka, P. Åtepnicka, ferrocenes: ligands, materials and biomolecules, John Wiley and Sons: England, 2008.
7. C. Biot, N. François, L. Maciejewski, J. Brocard, D. Poulain, Bioorg. Med. Chem. Lett. 2000, 10, 839.
8. M. El Arbi, P. Pigeon, S. Top, A. Rhouma, S. Aifa, A. Rebai, A. Vessières, M. Plamont, G. Jaouen, J. Organomet. Chem. 2011, 696, 1038.
9. P. J. Higgins, A. M. Gellett, Med. Chem. Lett. 2009, 19, 1614.
10. I. Hutchinson, S. A. Jennings, B. R. Vishnuvajjala, A. D. Westwell, M. F. G. Stevens, J. Med. Chem. 2002, 45, 744.
11. J. V. Metzger, The chemistry of heterocyclic compounds. Thiazole and its Derivatives: A Series of Monographs, Vol. 34, Wiley, Chichester, 1979.
12. D. Havrylyuk, B. Zimenkovsky, O. Vasylenko, L. Zaprutko, A. Gzella, R. Lesyk, Eur. J. Med. Chem. 2009, 44, 1396.
13. R. Lesyk, B. Zimenkovsky, Curr. Org. Chem. 2004, 8, 1547.
14. S. Bondock, W. Fadaly, M. A. Metwally, Eur. J. Med. Chem. 2010, 45, 3692.
15. M. C. Bagley, C. Glover, Tetrahedron 2006, 62, 66.
16. a) A. Hess, O. Brosch, T. Weyhermuller, N. Metzler-Nolte, J. Organomet. Chem. 1999, 589, 75
17. b) A. Hess, J. Sehnert, T. Weyhermuller, N. Metzler-Nolte, Inorg. Chem. 2000, 39, 5437
18. c) Y. N. Vashisht Gopal, D. Jayaraju, A. K. Kondapi, Arch. Biochem. Biophys. 2000, 376, 229
19. d) K. Heinze, U. Wild, M. Beckmann, Eur. J. Inorg. Chem. 2007, 4, 617
20. e) L. Barisic, V. Rapic, N. Metzler-Nolte, Eur. J. Inorg. Chem. 2006, 20, 4019
21. f) J. T. Chantson, M. V. V. Falzacappa, S. Crovella, N. Metzler-Nolte, Chem. Med. Chem. 2006, 1, 1268
22. g) S. K. Dey, H-B. Kraatz, Bioconjugate Chem. 2006, 17, 84
23. h) A. M. Gellett, P. W. Huber, P. J. Higgins, J. Organomet. Chem. 2008, 693, 2959.
24. M. M. Abd-Elzaher, W. Hegazy, A. Gaafar, Appl. Organometal. Chem. 2005, 19, 911.
25. a) M. M. Abd-Elzaher, S. M. El-shiekh, M. Eweis, Appl. Organometal. Chem. 2006, 20, 597
26. b) S. M. El-Shiekh, M. M. Abd-Elzaher, M. Eweis, Appl. Organometal. Chem. 2006, 20, 505.
27. M. M. Abd-Elzaher, Appl. Organometal. Chem. 2004, 18, 149.
28. M. M. Abd-Elzaher, S. A. Moustafa, A. A. Labib, M. M. Ali, Monatsh. Chem. 2010, 141, 387.
29. J. Fang, T. Seki, H. Maeda, Adv.Drug Deliver. Rev. 2009, 61, 290.
30. K. J. Davies, Biochem. Soc. Trans. 1993, 21, 346.
31. H. Pelicano, D. Carney, P. Huang, Drug Resist. Update 2004, 7, 97.
32. O. Ben-Yoseph, B. D. Ross, Br. J. Cancer 1994, 70, 1131.
33. A. Golcu, M. Tumer, H. Demirelli, R. A. Wheatley, Inorg. Chim. Acta 2005, 358, 1785.
34. A. B. P. Lever, Inorganic Electronic Spectroscopy, Elsevier, Amsterdam, 1984.
35. R. Huang, A. Wallqvist, D. G. Covell, Biochem. Pharmacol. 2005, 69, 1009.
36. K. Becker, C. Herold-Mende, J. J. Park, G. Lowe, R. H. Schirmer, J. Med. Chem. 2001, 44, 2784.
37. F. J. Blanco, R. L. Ochs, H. Schwarz, M. Lotz, Am. J. Pathol. 1995, 146, 75.
38. L. Molina y Vedia, B. McDonald, B. Reep, B. Brüne, M. Di Silvio, T. R. Billiar, E. G. Lapetina, J. Biol. Chem. 1992, 267, 24929.
39. J. J. Hibbs, R. R. Taintor, Z. Vavrin, E. M. Rachlin, Biophys. Res. Commun. 1988, 157, 87.
40. M. J. Juedes, G. N. Wogan, Mutat. Res. 1996, 349, 51.
41. M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, M. Fontecave, Biochem. Biophys. Res. Commun. 1991, 179, 442.
42. K. Fehsel, A. Jalowy, S. Qi, V. Burkart, B. Hartmann, H. Kolb, Diabetes 1993, 42, 496.
43. S. Dimmeler, A. M. Zeiher, Nitric Oxide 1997, 1, 275.
44. P. Bienvenu, L. Caron, D. Gasparutto, J. F. Kergonou, EXS 1992, 62, 257.
45. P. Huang, L. Feng, E. A. Oldham, M. J. Keating, W. Plunkett, Nature 2000, 407, 390.
46. D. A. Gewirtz, Biochem. Pharmacol. 1999, 57, 727.
47. M. Rosenblum, R. B. Woodward, J. Am. Chem. Soc. 1958, 80, 441.
48. T. Mosmann, J. Immunol. Methods 1983, 65, 55.
49. E. D. Paglia, W. N. Valentine, J. Lab. Clin. Med. 1967, 70, 158.
50. H. Aebi, Methods of Enzymatic Analysis, Academic Press, New York, 1984.
51. S. Marklund, G. Marklund, Eur. J. Biochem. 1974, 47, 469.
52. S. P. Wolff, Meth. Enzymol. 1994, 233, 182.
53. H. A. C. Montgomery, J. F. Dymock, Analyst 1961, 86, 414.
54. G. L. Ellman, Arch. Biochem. Biophys. 1959, 82, 70.
55. T. Zhou, G. Zhou, W. Song, N. Eguchi, W. Lu, E. Lundin, T. Jin, G. Nordberg, Toxicology 1999, 142, 1.
56. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 1951, 193, 265.